Baker Bros. Advisors LP 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:21 pm Sale |
2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
Baker Bros. Advisors LP | 7,881,933 4.990% |
-249,745 (-3.07%) |
Filing |
| 2022-02-14 4:15 pm Purchase |
2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
Baker Bros. Advisors LP | 8,131,678 8.000% |
66,846 (+0.83%) |
Filing |
| 2021-02-16 5:09 pm Purchase |
2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX |
Baker Bros. Advisors LP | 8,064,832 8.700% |
84,979 (+1.06%) |
Filing |